Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Pierre Fabre
Welcome,
Profile
Billing
Logout
26 Products
211 Diseases
26 Products
210 Trials
9834 News
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
16
32
48
64
80
96
112
128
144
160
Mektovi
(binimetinib) / Pfizer
Navelbine oral
(vinorelbine tartrate oral) / Pierre Fabre
Braftovi
(encorafenib) / Pfizer
Nerlynx
(neratinib) / Puma
Savella
(milnacipran) / AbbVie, Pierre Fabre
Javlor
(vinflunine) / Pierre Fabre
dalotuzumab
(MK 0646) / Merck (MSD), Pierre Fabre
Beova
(vibegron) / Merck (MSD)
Fetzima
(levomilnacipran ER) / Pierre Fabre, AbbVie
Condrosulf
(chondroitin sulfate) / IBSA Institute Biochemical SA, Pierre Fabre
TriptoSar
(omtriptolide) / Pierre Fabre
befiradol
(NLX-112) / Neurolixis
Tab-cel
(tabelecleucel) / Atara
recombinant ectodysplasin A1
(APO200) / Valerio Therap, Pierre Fabre
ibuprofen lozenges
(V-0498) / Pierre Fabre
F17464
/ Pierre Fabre
V-0162
/ Pierre Fabre
telisotuzumab
(h224G11) / AbbVie
F14512
/ Pierre Fabre
F373280
/ Pierre Fabre
STX-721
/ Pierre Fabre
W0180
/ Pierre Fabre
exarafenib
(KIN-2787) / Pierre Fabre
lonigutamab
(VB421) / Pierre Fabre, ACELYRIN
lonigutamab ugodotin
(W0101) / Pierre Fabre, Roche
